- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04246216
Percutaneous Electrical Nerve Stimulation for Carpal Tunnel Syndrome
February 6, 2023 updated by: César Fernández-de-las-Peñas, Universidad Rey Juan Carlos
Ultrasound-Guided Percutaneous Electrical Nerve Stimulation of the Median Nerve for Carpal Tunnel Syndrome
There is evidence supporting that physical therapy interventions can be effective for the management of patients with CTS.
No consensus on the best approach exist.
It seems clear that the median nerve is affected in several ways (compression, inflammation, excursion) in carpal tunnel syndrome.
Percutaneous Electrical Nerve Stimulation is a treatment approach consisting of the application of an electrical current throughout needling filaments placed close to the nerve, in this case the median nerve.
The purpose of this clinical trial is to compare changes in function, symptom severity and the intensity of pain after the application of Percutaneous Electrical Nerve Stimulation vs. endoscopic surgery in women with CTS at short- and long-term follow-up periods.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alcorcon, Madrid
-
Alcorcon, Alcorcon, Madrid, Spain, 28922
- César Fernández-de-las-Peñas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- pain and paresthesia in the median nerve distribution
- positive Tinel sign,
- positive Phalen sign,
- symptoms had to have persisted for at least 6 months
- deficits of sensory and motor median nerve conduction according to guidelines of the American Association of Electrodiagnosis, American Academy of Neurology, and the American Physical Medicine and Rehabilitation Academy
Exclusion Criteria:
- any sensory/motor deficit related to the ulnar or radial nerve;
- older than 65 years of age;
- previous surgical intervention, steroid injections or physical therapy intervention
- multiple diagnoses of the upper extremity (eg, cervical radiculopathy);
- history of neck, shoulder, or upper limb trauma (whiplash);
- history of any systemic disease causing CTS (eg, diabetes mellitus, thyroid disease);
- history of other systemic conditions (eg, rheumatoid arthritis, fibromyalgia);
- pregnancy;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Percutaneous Electrical Nerve Stimulation
The experimental group will receive 3 sessions (once per week) of ultrasound-guided Percutaneous Electrical Nerve Stimulation targeted the median nerve.
Once the median nerve is ultrasound identified, the needles will be left in situ at the identified points connected to an electrostimulator (ES-160 ITO co.) applying a biphasic continuous waveform, at low frequency (2 Hz)19 and with 250 microseconds pulse duration for 30mins.
|
Experimental: Percutaneous Electrical Nerve Stimulation The experimental group will receive 3 sessions (once per week) of ultrasound-guided Percutaneous Electrical Nerve Stimulation targeted the median nerve.
Once the median nerve is ultrasound identified, the needles will be left in situ at the identified points connected to an electrostimulator (ES-160 ITO co.) applying a biphasic continuous waveform, at low frequency (2 Hz)19 and with 250 microseconds pulse duration for 30mins.
|
ACTIVE_COMPARATOR: Surgery
The surgical group will receive a surgical procedure consisting of the decompression and release of the median nerve at the carpal tunnel performed by an experienced surgeon according to standardized protocols.
|
The surgical group will receive a surgical procedure consisting of the decompression and release of the median nerve at the carpal tunnel performed by an experienced surgeon according to standardized protocols.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in pain intensity between baseline and follow-up periods
Time Frame: Baseline and 1, 3, 6 and 12 months after the intervention.
|
An 11-point Numerical Pain Rating Scale (NPRS, 0: no pain - 10: maximum pain) will be used to assess the patients' current level of hand pain and the worst and lowest level of pain experienced in the preceding week.
|
Baseline and 1, 3, 6 and 12 months after the intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in hand function between baseline and follow-up periods
Time Frame: Baseline and 1, 3, 6 and 12 months after the intervention.
|
The Spanish version of the Boston Carpal Tunnel Questionnaire (BCTQ) will be used to assess function.
This questionnaire evaluates 2 domains: 1) the functional status scale assesses ability to perform 8 common hand-related tasks; and, 2) the symptom severity scale includes 11 items assessing pain severity, numbness, and weakness at night and during the day.
Each question is answered on a 5-point scale (1: no complaint; 5: severe complaint), with higher scores indicating greater severity.
|
Baseline and 1, 3, 6 and 12 months after the intervention.
|
Changes in severity between baseline and follow-up periods
Time Frame: Baseline and 1, 3, 6 and 12 months after the intervention.
|
The Spanish version of the Boston Carpal Tunnel Questionnaire (BCTQ) will be used to assess function.
This questionnaire evaluates 2 domains: 1) the functional status scale assesses ability to perform 8 common hand-related tasks; and, 2) the symptom severity scale includes 11 items assessing pain severity, numbness, and weakness at night and during the day.
Each question is answered on a 5-point scale (1: no complaint; 5: severe complaint), with higher scores indicating greater severity.
|
Baseline and 1, 3, 6 and 12 months after the intervention.
|
Changes in patient self-perceived improvement between baseline and follow-up periods
Time Frame: Baseline and 1, 3, 6 and 12 months after the intervention.
|
. Subjects self-perceived improvement will be assessed using a Global Rating of Change (GROC) which consists of a 15-point scale ranging from -7 (a very great deal worse) to +7 (a very great deal better).
It has been reported that scores of +4 and +5 are indicative of moderate changes in patient status, whereas scores of +6 and +7 indicate large changes in the status of the patient.
|
Baseline and 1, 3, 6 and 12 months after the intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 1, 2020
Primary Completion (ACTUAL)
March 31, 2021
Study Completion (ACTUAL)
March 31, 2022
Study Registration Dates
First Submitted
January 27, 2020
First Submitted That Met QC Criteria
January 27, 2020
First Posted (ACTUAL)
January 29, 2020
Study Record Updates
Last Update Posted (ACTUAL)
February 8, 2023
Last Update Submitted That Met QC Criteria
February 6, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- URJC0209201911819
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carpal Tunnel Syndrome
-
Stanford UniversityMayo Clinic; Brown University; Duke University; Harvard University; University of...CompletedCarpal Tunnel Syndrome | Carpal Tunnel | Carpal Tunnel Syndrome Bilateral | Carpal Tunnel Syndrome Left | Carpal Tunnel Syndrome RightUnited States
-
Issa, Abdulhamid Sayed, M.D.CompletedCarpal Tunnel Syndrome | CTS | Carpal Tunnel Release | Carpal Tunnel Surgery | Carpal Tunnel Transverse ApproachSyrian Arab Republic
-
Ohio State UniversityCompletedBilateral Carpal Tunnel Syndrome (Diagnosis)United States
-
University of Split, School of MedicineCompletedCarpal Tunnel Syndrome BilateralCroatia
-
CMC Ambroise ParéCompletedCarpal Tunnel ReleaseFrance
-
Vanderbilt UniversityOrthopedic Research and Education FoundationCompleted
-
University of PittsburghWithdrawnPain After Carpal Tunnel ReleaseUnited States
-
Centre Hospitalier Saint Joseph Saint Luc de LyonRecruitingCarpal Tunnel Syndrome BilateralFrance
-
Istituto Ortopedico RizzoliCompletedEntrapment Neuropathy, Carpal Tunnel | Compression Neuropathy, Carpal Tunnel | Median Neuropathy, Carpal TunnelItaly
-
David TangRecruitingCarpal Tunnel Syndrome | Splints | Carpal Tunnel | Nerve Compression | Carpal Tunnel Release | Hand Injuries and DisordersCanada
Clinical Trials on Percutaneous Electrical Nerve Stimulation
-
César Fernández-de-las-PeñasActive, not recruiting
-
Children's Hospital of Orange CountyInnovative Health SolutionsRecruitingCOVID-19 | Post-Concussion Syndrome | COVID Long-HaulUnited States
-
InventramKoç UniversityCompletedParkinson DiseaseTurkey
-
Medical College of WisconsinUniversity College, London; Indiana UniversityRecruitingFunctional Gastrointestinal Disorders | Postural Orthostatic Tachycardia Syndrome | Hypermobile Ehlers-Danlos Syndrome | Autonomic Nervous System Disease | Autonomic Nervous System ImbalanceUnited States
-
Universidad Rey Juan CarlosRecruitingNeuropathic Pain | Peripheral Neuropathy | Percutaneous Electrical Nerve StimulationSpain
-
Medical College of WisconsinChildren's Wisconsin; Advancing a Healthier Wisconsin Endowment (AHW)RecruitingParoxysmal Sympathetic HyperactivityUnited States
-
Karolinska University HospitalActive, not recruitingHip Fractures | Hip Osteoarthritis | Orthopedic Disorder | Post Operative PainSweden
-
Xijing HospitalRecruitingChronic Prostatitis | Chronic Pelvic PainChina
-
University of L'AquilaCompleted
-
University of California, San DiegoCopenhagen University Hospital at Herlev; University California Academic Senate and other collaboratorsCompletedPostoperative PainUnited States